Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Condition:   Meningococcal Infections Intervention:   Biological: Meningococcal Group ACYW135 Conjugate Vaccine Sponsor:   Walvax Biotechnology Co., Ltd. Completed

Source: ClinicalTrials.gov - January 22, 2020 Category: Research Source Type: clinical trials